Suppr超能文献

帕金森病中纹状体血脑屏障的通透性

Striatal blood-brain barrier permeability in Parkinson's disease.

作者信息

Gray Madison T, Woulfe John M

机构信息

1] Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada [2] Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

1] Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada [2] Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada [3] Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

出版信息

J Cereb Blood Flow Metab. 2015 May;35(5):747-50. doi: 10.1038/jcbfm.2015.32. Epub 2015 Mar 11.

Abstract

In vivo studies have shown that blood-brain barrier (BBB) dysfunction is involved in the course of Parkinson's disease (PD). However, these have lacked either anatomic definition or the ability to recognize minute changes in BBB integrity. Here, using histologic markers of serum protein, iron, and erythrocyte extravasation, we have shown significantly increased permeability of the BBB in the postcommissural putamen of PD patients. The dense innervation of the striatum by PD-affected regions allows for exploitation of this permeability for therapeutic goals. These results are also discussed in the context of the retrograde trans-synaptic hypothesis of PD spread.

摘要

体内研究表明,血脑屏障(BBB)功能障碍与帕金森病(PD)的病程有关。然而,这些研究要么缺乏解剖学定义,要么缺乏识别血脑屏障完整性微小变化的能力。在这里,我们使用血清蛋白、铁和红细胞外渗的组织学标记物,发现PD患者连合后壳核中的血脑屏障通透性显著增加。受PD影响区域对纹状体的密集神经支配使得利用这种通透性实现治疗目标成为可能。我们还在PD传播的逆行跨突触假说的背景下讨论了这些结果。

相似文献

1
Striatal blood-brain barrier permeability in Parkinson's disease.
J Cereb Blood Flow Metab. 2015 May;35(5):747-50. doi: 10.1038/jcbfm.2015.32. Epub 2015 Mar 11.
3
Erythrocytes, a New Contributor to Age-Associated Loss of Blood-Brain Barrier Integrity.
Adv Sci (Weinh). 2021 Oct;8(20):e2101912. doi: 10.1002/advs.202101912. Epub 2021 Aug 16.
5
String Vessel Formation is Increased in the Brain of Parkinson Disease.
J Parkinsons Dis. 2015;5(4):821-36. doi: 10.3233/JPD-140454.
6
Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy.
Transl Neurodegener. 2024 Jul 29;13(1):37. doi: 10.1186/s40035-024-00430-z.
7
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.
8
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.
10
Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.
Cell Transplant. 2007;16(3):285-99. doi: 10.3727/000000007783464731.

引用本文的文献

2
Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment.
Front Aging Neurosci. 2025 Aug 7;17:1640389. doi: 10.3389/fnagi.2025.1640389. eCollection 2025.
3
Elevated plasma levels of alpha-synuclein are dispensable for Parkinson's disease pathology.
NPJ Parkinsons Dis. 2025 Aug 4;11(1):228. doi: 10.1038/s41531-025-01091-z.
5
Restoring brain barriers: an innovative approach for treating neurological disorders.
Fluids Barriers CNS. 2025 Jul 10;22(1):72. doi: 10.1186/s12987-025-00688-z.
7
Sleep Disturbance in Parkinson's Disease: Consequences for the Brain and Disease Progression - A Narrative Review.
Nat Sci Sleep. 2025 Jun 28;17:1521-1537. doi: 10.2147/NSS.S478860. eCollection 2025.
8
9
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications.
Antioxidants (Basel). 2025 Apr 28;14(5):527. doi: 10.3390/antiox14050527.

本文引用的文献

1
Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease.
Parkinsonism Relat Disord. 2014 Jul;20(7):685-94. doi: 10.1016/j.parkreldis.2014.02.031. Epub 2014 Mar 26.
2
Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease.
Brain Pathol. 2013 May;23(3):303-10. doi: 10.1111/bpa.12004. Epub 2012 Nov 28.
3
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport.
Ann Neurol. 2012 Oct;72(4):517-24. doi: 10.1002/ana.23747.
4
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.
Acta Neuropathol. 2013 Jan;125(1):111-20. doi: 10.1007/s00401-012-1039-8. Epub 2012 Sep 1.
5
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease.
J Neuroinflammation. 2012 Aug 8;9:188. doi: 10.1186/1742-2094-9-188.
6
Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration.
PLoS One. 2011;6(10):e26612. doi: 10.1371/journal.pone.0026612. Epub 2011 Oct 19.
8
9
Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.
Acta Neuropathol. 2010 Aug;120(2):145-54. doi: 10.1007/s00401-010-0676-z. Epub 2010 Mar 26.
10
Severe blood-brain barrier disruption and surrounding tissue injury.
Stroke. 2009 Dec;40(12):e666-74. doi: 10.1161/STROKEAHA.109.551341. Epub 2009 Nov 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验